Degenerative Disc Disease News

K2M Receives 510(k) Clearance For Its CHESAPEAKE Anterior-Lumbar Stabilization SystemWednesday, September 8, 2010 @ 11:26AMK2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its new CHESAPEAKE™ Anterior-Lumbar Stabilization System, a unique interbody device designed for stabilization of the spine through an anterior approach. The system provides screw ...

Reportlinker Adds Gene Therapy - Technologies, Markets and CompaniesTuesday, September 7, 2010 @ 3:51PMReportlinker.com announces that a new market research report is available in its catalogue:

K2M granted FDA clearance for CHESAPEAKE Anterior-Lumbar Stabilization SystemTuesday, September 7, 2010 @ 2:42PMK2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market its new CHESAPEAKE™ Anterior-Lumbar Stabilization System, a unique interbody device designed for stabilization of the spine through an anterior approach. The system provides screw ...

K2M Receives 510(k) Clearance for its CHESAPEAKE Anterior-Lumbar Stabilization SystemTuesday, September 7, 2010 @ 1:15PMLEESBURG, Va.--(BUSINESS WIRE)--K2M, Inc. announced 510(k) clearance from FDA to market CHESAPEAKE Anterior-Lumbar Stabilization System, an interbody device designed for stabilization of spine through anterior approach.

K2M Receives 510(k) Clearance for its CHESAPEAKE Anterior-Lumbar Stabilization SystemTuesday, September 7, 2010 @ 1:00PMLEESBURG, Va.----K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies, today announced it has received 510 clearance from the U.S.